Boca Raton doctor explains new FDA-approved Alzheimer's treatment
The drug by Eli Lilly, Donanemab, becomes the second drug that shows delayed cognitive decline in patients. |!| Palm Beach Palm Beach Gardens Boca Raton
The drug by Eli Lilly, Donanemab, becomes the second drug that shows delayed cognitive decline in patients. |!| Palm Beach Palm Beach Gardens Boca Raton